T1	HMM 1872 1903	vaccine-related serious adverse
T2	HMM 1926 1951	We recorded local adverse
T3	HMM 2106 2120	placebo group.
T4	HMM 2121 2128	Fatigue
T5	HMM 2421 2433	respectively
T6	HMM 2602 2616	placebo group.
T7	HMM 2617 2691	Geometric mean concentrations of IgG antibodies against Ebola glycoprotein
T8	HMM 2931 2966	(86路5-99路5), and 5% (0路1-24路9).
T9	HMM 2967 2976	Geometric
T10	HMM 3238 3305	participants given low-dose vaccine developed glycoprotein-specific
T11	HMM 3381 3390	responses
T12	HMM 3392 3406	INTERPRETATION
